BioSpace News Archive

Samus Therapeutics, Inc. (“Samus Therapeutics” or the “Company”), today announced the publication on November 25, 2021 of an open article in Communications Biology about how epichaperome inhibition by zelavespib (PU-H71) can increase the vulnerability of cancer cells to traditionally poor performing therapeutics.

Karyopharm Therapeutics Inc. today announced it will host a virtual Investor Day on Wednesday, December 8, 2021 from 10:00 a.m. to 12:30 p.m. ET.

BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) has appointed renowned astronaut Chris Hadfield to its board of advisors as part of a drive to leverage its biotech technology platform.

Genesis Innovation Group’s cultivate(MD) Capital Funds announces that one of their portfolio companies, Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, has raised $46 million in a Series C funding round.

Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the annual American Society of Hematology (ASH) meeting.

Parthenon Therapeutics today announced the appointment of Tamas Oravecz, Ph.D., as Chief Scientific Officer.

AVEO Oncology Announces Appointment of Jeb Ledell as Chief Operating Officer.

Gelesis, a consumer-focused biotherapeutics company, is proud to announce Plenity®, an FDA cleared weight management approach, is now broadly available across the United States to adults who meet the prescription criteria.

Paragon 28, Inc. announced today the appointment of B. Kristine Johnson and Kristina Wright to the Board of Directors, effective December 1, 2021.

Immunome, Inc. announced today that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529).